Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
It’s in your fridge and now, scientists are studying it to help patients with type one diabetes. Lettuce could soon help the millions of people in the United States diagnosed with this chronic disease. "This is a totally new concept," says Henry Daniell, Ph.D., a molecular biologist at the University of Central Florida in Orlando, Fla.
For the past 20 years, Dr. Daniell has worked to perfect the method. He injects the human gene for insulin into leaves of lettuce that are grown in the lab. The leaves can be ground into a powder and put into a capsule.
"What we have done is teach the body how to cure this disorder," Dr. Daniell said.
The lettuce helps the powdered capsule reach the intestine. There, plant cells meet with bacteria and release the insulin. This stimulates an immune response and tells the body to produce its own insulin.
 |
|
The first test was in animals. After eight weeks, all the diabetic mice had normal blood sugar levels and produced insulin — even after they stopped taking the lettuce. Now, human trials are planned. Dr. Daniell says if all goes well, this could be a permanent solution.
"It would mean everything in the world to me. I could literally give up everything, other than my family, to have a cure," Beckman proclaimed. Research is one step closer to giving him just that.
Dr. Daniell says patients would only have to take the pill for weeks, not months or years. Once their immune system responds, they would essentially no longer have the disease. He also says because this is a plant-based therapy, it would only cost pennies to produce. There were no side effects observed in the mice. Human trials are expected to start in the next year.
https://daniell.ucf.edu/videos/show/nbc6
============================
DID YOU KNOW:
Byetta Extends Lives: According to the results of a major clinical trial, patients who took Byetta had a much lower chance of dying, about 75 percent lower, than those who took any other drug in the ACCORD trial. The results even surprised those at Lilly and Amylin.
See This Weeks’ Item #8
===============================
Help us keep this newsletter free-update your profile.
https://www.diabetesincontrol.com/surveys/index.php